The Use of Decision-Analytic Models in Atopic Eczema: A Systematic Review and Critical Appraisal.

about

Quality assessment of atopic dermatitis clinical practice guidelines in ≤ 18 years.

P2860

Q47845620-6E106ABE-405E-40DE-A2CA-E2213A08A230

P2860

The Use of Decision-Analytic Models in Atopic Eczema: A Systematic Review and Critical Appraisal.

Item

http://www.wikidata.org/entity/Q38597139

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The Use of Decision-Analytic M ...... Review and Critical Appraisal.

@en

type

Item

label

The Use of Decision-Analytic M ...... Review and Critical Appraisal.

@en

prefLabel

The Use of Decision-Analytic M ...... Review and Critical Appraisal.

@en

P1476

The Use of Decision-Analytic M ...... Review and Critical Appraisal

@en

P2093

Emma McManus

http://www.w3.org/2001/XMLSchema#string

Nick Levell

http://www.w3.org/2001/XMLSchema#string

Tracey Sach

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus Decision Models for Biologics in Rheumatoid and Psoriatic Arthritis: Recommendations of a Multidisciplinary Working Party.

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

The cost-effectiveness of universal newborn screening for bilateral permanent congenital hearing impairment: systematic review.

Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.

Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.

Mapping randomized controlled trials of treatments for eczema--the GREAT database (the Global Resource of EczemA Trials: a collection of key data on randomized controlled trials of treatments for eczema from 2000 to 2010)

Handling uncertainty in cost-effectiveness models.

Clinical practice. Atopic dermatitis.

Quality-of-life outcomes and measurement in childhood atopic dermatitis

The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review

P2888

s40273-017-0564-7

P304

51-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40273-017-0564-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tracey Sach

Nick Levell

E McManus

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28864846

http://www.w3.org/2001/XMLSchema#string

The Use of Decision-Analytic Models in Atopic Eczema: A Systematic Review and Critical Appraisal.

about

P2860

P2860

The Use of Decision-Analytic Models in Atopic Eczema: A Systematic Review and Critical Appraisal.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698